Delavan approves annexing land for medicinal marijuana growing

Delavan approves annexing land for medicinal marijuana growing

By Chris Lovingood

July 1, 2014 Updated Jul 2, 2014 at 9:46 AM CDT

DELAVAN, Ill. -- Delavan city officials have agreed to annex a part of the town's land for a medical marijuana growing plant.

The Illinois Cannabis Company is expected to apply for a license to construct a facility to grow in Delavan next month. They say it will bring 50 to 60 new jobs to town, but not everyone is thrilled.

The room during Tuesday's council meeting seemed divided on the issue.

One main concern was the possible moral decay that could come with the facility.

Only one council member voted against annexing the land. Alderman George Mitchell says he's worried about what the facility could potentially expand to.

He says he wants the community to be developed, but he just can't support this sort of thing.

News 25 tried to talk to him on camera after the meeting, but he declined. However, he told us he believes other states have made it clear that allowing weed to be grown for medicinal purposes is a slippery slope to other things such as legalizing it for recreational use.

One local resident agreed with Mitchell.

"This town has been here for 150 years without it," said Ted Yontz. "We can survive without it also."

Another resident spoke up in favor of the plant. Michael McDonald previously lived in Peoria for 20 years, and says he's seen what happened when the town turned down having the Par-A-Dice Casino.

"I think seeing how East Peoria has grown and developed, I can see what it can do for [Delavan]," said McDonald. "I think something like this for Delavan could bring the same prosperity to not only the school, but the town."

If ICC Holding's application is approved, they'll have a six month deadline to construct their growing center.

At Monday's zoning board meeting, Tim McGraw with the growing company wanted to assure Delavan's residents marijuana would only be grown at and shipped from the facility, not sold.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.